Michael Lauzardo, MD, MSc
Associate Professor Of Medicine; Deputy Director Of Emerging Pathogens Institute
Department:
MD-MEDICINE GLOBAL HEALTH
Business Phone:
(352) 273-9378
Business Email:
mike.lauzardo@medicine.ufl.edu
About Michael Lauzardo
Michael Lauzardo, MD, MSc, is an associate professor within the division of infectious diseases and global medicine. Also serving as the director of the CDC funded Southeastern National Tuberculosis Center (SNTC) at the University of Florida, he has been involved in public health, teaching and patient care within the College of Medicine since 1997. Trained as an internist and pulmonologist, throughout his career he has been involved in the clinical care of patients with tuberculosis. He has also played a key role with the Florida Department of Health, serving as the Deputy TB Controller for the Florida TB Program and is currently the director of the Florida TB Physicians Network. Previously, he was the chief of the division of infectious diseases and global medicine. His clinical practice and research centers around tuberculosis among at-risk populations and he is involved in various international health activities.
Accomplishments
Vice President/Program Chair North American Region
2008-2010
·
International Union Against Tuberculosis and Lung Disease
Bryant L. Galusha Internship Award-Intern of the Year
1992
·
Carolinas Medical Center
Teaching Profile
Courses Taught
2018-2020
IDH2930 (Un)common read
2020
PHC6937 Special Topics in Public Health
2018
MDT7090 Elective Topics
2018,2024
BMS6300 Fund Micro and Immuno
2015-2016,2023-2024
PHC7980 Research for Doctoral Dissertation
2012,2014-2022,2022-2023
PHC7979 Advanced Research
2021,2023-2024
PHC7918 Independent Study
2024
PAS5009 Behav and Commnty Med 2
Board Certifications
-
Pulmonary DiseaseAmerican Board of Internal Medicine
Clinical Profile
Specialties
- Infectious Disease
Areas of Interest
- Pulmonary Tuberculosis
Research Profile
Professional Memberships: 2003-present: National TB Controllers Association 1997-present: American Thoracic Society 1997-present: International Union Against Tuberculosis and Lung Disease 1996-2000: American College of Chest Physicians 1987-1991: Christian Medical Society
Areas of Interest
- Global Health
- Latent tuberculosis treatment
- Molecular epidemiology of tuberculosis
- Tuberculosis treatment
Publications
2024
Comparison of Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting Tuberculosis Disease.
JAMA network open.
7(4)
[DOI] 10.1001/jamanetworkopen.2024.4769.
[PMID] 38568690.
2023
Application of Phylodynamic Tools to Inform the Public Health Response to COVID-19: Qualitative Analysis of Expert Opinions.
JMIR formative research.
7
[DOI] 10.2196/39409.
[PMID] 36848460.
2023
Central Nervous System Tuberculosis: Risk Factors for Mortality in a Propensity Score-Matched Case-Control Study.
Open forum infectious diseases.
10(12)
[DOI] 10.1093/ofid/ofad559.
[PMID] 38088977.
2023
Lack of SARS-CoV-2 in environmental samples collected from September 2020-February 2021 in a university that followed CDC reopening guidance.
Hygiene and environmental health advances.
7
[DOI] 10.1016/j.heha.2023.100061.
[PMID] 37305381.
2023
Multicenter matched-pair study comparing BACT/ALERT® MP reagent systems for the recovery of mycobacteria from specimens other than blood.
Diagnostic microbiology and infectious disease.
107(2)
[DOI] 10.1016/j.diagmicrobio.2023.115959.
[PMID] 37536260.
2023
Retrospective Analysis of Wastewater-Based Epidemiology of SARS-CoV-2 in Residences on a Large College Campus: Relationships between Wastewater Outcomes and COVID-19 Cases across Two Semesters with Different COVID-19 Mitigation Policies.
ACS ES&T water.
3(1):16-29
[DOI] 10.1021/acsestwater.2c00275.
[PMID] 37552720.
2022
Applying Lean principles to create a high throughput mass COVID-19 vaccination site.
BMJ open quality.
11(1)
[DOI] 10.1136/bmjoq-2021-001617.
[PMID] 35131743.
2022
Assessing risk factors for latent and active tuberculosis among persons living with HIV in Florida: A comparison of self-reports and medical records.
PloS one.
17(8)
[DOI] 10.1371/journal.pone.0271917.
[PMID] 35925972.
2022
Evaluation of screen, test, & protect: A public health program to control and prevent COVID-19 at a large academic university.
Journal of American college health : J of ACH.
1-4
[DOI] 10.1080/07448481.2022.2080506.
[PMID] 35727228.
2022
Low-frequency variants in mildly symptomatic vaccine breakthrough infections presents a doubled-edged sword.
Journal of medical virology.
94(7):3192-3202
[DOI] 10.1002/jmv.27726.
[PMID] 35307848.
2022
Multi-Faceted Approach to COVID-19 Surveillance at a Large University Campus in the Southeastern United States.
Disaster medicine and public health preparedness.
17
[DOI] 10.1017/dmp.2022.109.
[PMID] 35492011.
2022
Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, Florida.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
75(9):1618-1627
[DOI] 10.1093/cid/ciac197.
[PMID] 35271704.
2021
An Outbreak of COVID-19 Among H-2A Temporary Agricultural Workers.
American journal of public health.
111(4):571-573
[DOI] 10.2105/AJPH.2020.306082.
[PMID] 33689435.
2021
Detection of SARS-CoV-2 in the gastrointestinal tract among patients with negative nasopharyngeal COVID-19 testing prior to endoscopy.
Endoscopy international open.
9(8):E1276-E1282
[DOI] 10.1055/a-1490-9234.
[PMID] 34447876.
2021
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
25(1):36-42
[DOI] 10.5588/ijtld.20.0301.
[PMID] 33384043.
2021
Effect of mixed strain infections on clinical and epidemiological features of tuberculosis in Florida.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
87
[DOI] 10.1016/j.meegid.2020.104659.
[PMID] 33276149.
2021
Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
108:212-216
[DOI] 10.1016/j.ijid.2021.04.063.
[PMID] 33901650.
2021
Observed Face Mask Use at Six Universities – United States, September-November 2020.
MMWR. Morbidity and mortality weekly report.
70(6):208-211
[DOI] 10.15585/mmwr.mm7006e1.
[PMID] 33571175.
2021
Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
73(7):e2278-e2284
[DOI] 10.1093/cid/ciaa1135.
[PMID] 32761083.
2020
Tuberculosis transmission across three states: The story of a solid organ donor born in an endemic country, 2018.
Transplant infectious disease : an official journal of the Transplantation Society.
22(6)
[DOI] 10.1111/tid.13357.
[PMID] 32510808.
2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
100:476-482
[DOI] 10.1016/j.ijid.2020.09.025.
[PMID] 32949774.
2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients.
medRxiv : the preprint server for health sciences.
[DOI] 10.1101/2020.08.03.20167395.
[PMID] 32793914.
2019
Direct transmission of within-host Mycobacterium tuberculosis diversity to secondary cases can lead to variable between-host heterogeneity without de novo mutation: A genomic investigation.
EBioMedicine.
47:293-300
[DOI] 10.1016/j.ebiom.2019.08.010.
[PMID] 31420303.
2019
Eliminating tuberculosis: the importance of paediatric tuberculosis surveillance.
The Lancet. Public health.
4(10):e485-e486
[DOI] 10.1016/S2468-2667(19)30148-3.
[PMID] 31446051.
2019
Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis.
American journal of epidemiology.
188(9):1733-1741
[DOI] 10.1093/aje/kwz147.
[PMID] 31251797.
2019
Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis.
BMC public health.
19(1)
[DOI] 10.1186/s12889-019-7524-4.
[PMID] 31481046.
2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
American journal of respiratory and critical care medicine.
200(10):e93-e142
[DOI] 10.1164/rccm.201909-1874ST.
[PMID] 31729908.
2019
Tuberculosis in the United States: Medical Consultation Services Provided by 5 Tuberculosis Regional Training and Medical Consultation Centers, 2013-2017.
Open forum infectious diseases.
6(6)
[DOI] 10.1093/ofid/ofz167.
[PMID] 31205971.
2019
Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
PloS one.
14(6)
[DOI] 10.1371/journal.pone.0213046.
[PMID] 31166945.
2018
Genetic diversity of drug and multidrug-resistant Mycobacterium tuberculosis circulating in Veracruz, Mexico.
PloS one.
13(3)
[DOI] 10.1371/journal.pone.0193626.
[PMID] 29543819.
2018
Genomic Investigation of a Mycobacterium tuberculosis Outbreak Involving Prison and Community Cases in Florida, United States.
The American journal of tropical medicine and hygiene.
99(4):867-874
[DOI] 10.4269/ajtmh.17-0700.
[PMID] 29987998.
2018
Health care workers’ recommendations for strengthening tuberculosis infection control in the Dominican Republic.
Revista panamericana de salud publica = Pan American journal of public health.
42
[DOI] 10.26633/RPSP.2018.169.
[PMID] 31093197.
2018
Management and diagnosis of tuberculosis in solid organ transplant candidates and recipients: Expert survey and updated review.
Journal of clinical tuberculosis and other mycobacterial diseases.
11:37-46
[DOI] 10.1016/j.jctube.2018.04.001.
[PMID] 31720390.
2018
Moving Closer to Tuberculosis Elimination through Institutional Scientific Collaboration: Opportunities for Cuba and the USA.
MEDICC review.
20(2):59-63
[DOI] 10.37757/MR2018.V20.N2.14.
[PMID] 29773780.
2018
Mycobacterium bovis BCG spinal osteomyelitis in a patient with bladder cancer without a history of BCG instillation.
BMJ case reports.
2018
[DOI] 10.1136/bcr-2018-224462.
[PMID] 30065051.
2018
Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.
Annals of the American Thoracic Society.
15(6):683-692
[DOI] 10.1513/AnnalsATS.201705-405OC.
[PMID] 29490150.
2017
Association between Mycobacterium tuberculosis lineage and site of disease in Florida, 2009-2015.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
55:366-371
[DOI] 10.1016/j.meegid.2017.10.004.
[PMID] 28993293.
2017
Perceived Barriers to Adherence to Tuberculosis Infection Control Measures among Health Care Workers in the Dominican Republic.
MEDICC review.
19(1):16-22
[DOI] 10.37757/MR2017.V19.N1.4.
[PMID] 28225541.
2017
The Role of Powerlessness Among Health Care Workers in Tuberculosis Infection Control.
Qualitative health research.
27(14):2116-2127
[DOI] 10.1177/1049732317731317.
[PMID] 28962542.
2016
Spatiotemporal Clustering of Mycobacterium tuberculosis Complex Genotypes in Florida: Genetic Diversity Segregated by Country of Birth.
PloS one.
11(4)
[DOI] 10.1371/journal.pone.0153575.
[PMID] 27093156.
2016
Tuberculosis therapy for 2016 and beyond.
Expert opinion on pharmacotherapy.
17(14):1859-72
[DOI] 10.1080/14656566.2016.1215428.
[PMID] 27457206.
2015
Description of the population structure and genetic diversity of tuberculosis in Estado de México, a low prevalence setting from Mexico.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
123(2):116-22
[DOI] 10.1111/apm.12312.
[PMID] 25257651.
2015
Hepatotoxicity from antituberculous therapy in the elderly: a systematic review.
Tuberculosis (Edinburgh, Scotland).
95(2):112-22
[DOI] 10.1016/j.tube.2014.10.006.
[PMID] 25595441.
2015
Is the Beijing strain of Mycobacterium tuberculosis associated with cavitary lung disease?
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
33:1-5
[DOI] 10.1016/j.meegid.2015.04.012.
[PMID] 25891279.
2015
Mutations conferring resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis clinical isolates in southeast Mexico.
International journal of antimicrobial agents.
45(6):671-3
[DOI] 10.1016/j.ijantimicag.2015.02.006.
[PMID] 25819011.
2015
Mycobacterium tuberculosis complex transmission is not associated with recent immigration (≤5 years) in Florida.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
36:547-551
[DOI] 10.1016/j.meegid.2015.08.038.
[PMID] 26325684.
2015
Optimizing the dose of rifapentine to treat tuberculosis. It’s elementary.
American journal of respiratory and critical care medicine.
191(3):251-2
[DOI] 10.1164/rccm.201412-2257ED.
[PMID] 25635488.
2015
Transmissibility of tuberculosis among school contacts: an outbreak investigation in a boarding middle school, China.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
32:148-55
[DOI] 10.1016/j.meegid.2015.03.001.
[PMID] 25757905.
2014
Advances in diagnosis and treatment of latent tuberculosis infection.
Journal of the American Board of Family Medicine : JABFM.
27(5):704-12
[DOI] 10.3122/jabfm.2014.05.140062.
[PMID] 25201941.
2012
Anticipated tuberculosis stigma among health professionals and Haitian patients in South Florida.
Journal of health care for the poor and underserved.
23(2):636-50
[DOI] 10.1353/hpu.2012.0046.
[PMID] 22643613.
2012
Antituberculosis therapy for 2012 and beyond.
Expert opinion on pharmacotherapy.
13(4):511-26
[DOI] 10.1517/14656566.2012.657176.
[PMID] 22332895.
2011
Decreased Early Mortality and Increased Survival With Less Intensive Therapy for Acute Lymphoblastic Leukemia (All) in the Dominican Republic (Dr)
Pediatric Blood & Cancer.
57
2011
Web-accessible database of hsp65 sequences from Mycobacterium reference strains.
Journal of clinical microbiology.
49(6):2296-303
[DOI] 10.1128/JCM.02602-10.
[PMID] 21450960.
2010
Stigma and Therapy Completion for Latent Tuberculosis among Haitian-origin Patients.
Florida public health review.
7:32-38
[PMID] 22866274.
2010
Structural forces and the production of TB-related stigma among Haitians in two contexts.
Social science & medicine (1982).
71(8):1409-17
[DOI] 10.1016/j.socscimed.2010.07.017.
[PMID] 20724052.
2009
Will new TB tests be effective in HIV-infected individuals?
HIV clinician.
21(2):13-4
[PMID] 19517623.
2004
Cultural feasibility assessment of tuberculosis prevention among persons of Haitian origin in South Florida.
Journal of immigrant health.
6(2):63-9
[PMID] 15014223.
2000
Phthisiology at the dawn of the new century.
Chest.
117(5):1455-73
[PMID] 10807837.
1994
Treatment of nocturnal leg cramps.
Archives of internal medicine.
154(9):1037-8
[PMID] 8179448.
Grants
Jul 2023
ACTIVE
Strengthening Civil Surgeons Capacity to Improve LTBI Surveillance and Outcomes Among Status Adjusters
Role: Principal Investigator
Funding: FL DEPT OF HLTH
via CTRS FOR DISEASE CONTROL AND PREVENTION
Jul 2023
ACTIVE
TB Physicians Consultation Network
Role: Principal Investigator
Funding: FL DEPT OF HLTH
via CTRS FOR DISEASE CONTROL AND PREVENTION
Jan 2023
ACTIVE
Southeastern National Tuberculosis Center at the University of Florida
Role: Principal Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Nov 2022
– Jun 2023
Strengthening Civil Surgeons Capacity to Improve LTBI Surveillance and Outcomes Among Status Adjusters
Role: Principal Investigator
Funding: FL DEPT OF HLTH
via CTRS FOR DISEASE CONTROL AND PREVENTION
Jul 2022
– Jun 2023
TB Physicians Consultation Network
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Mar 2022
– Jun 2022
TB Physicians Consultation Network
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Jul 2021
ACTIVE
CDC-RFA-IP21-2113
Role: Project Manager
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Jul 2021
ACTIVE
Linking within- and between-host dynamics in tracking recent Mycobacterium tuberculosis transmission
Role: Other
Funding: NATL INST OF HLTH NIAID
Apr 2021
– Mar 2022
CoVPN 3006 Protocol Funding (PF) – Gainesville Protocol-Specific Site
Role: Co-Investigator
Funding: FRED HUTCHINSON CANCER CENTER
via NATL INST OF HLTH NIAID
Feb 2021
– Nov 2021
A randomized study to assess the efficacy of SARS-CoV-2 EUA vaccine in preventing SARS-CoV-2 infection and viral shedding in US college students
Role: Co-Investigator
Funding: FRED HUTCHINSON CANCER CENTER
via NATL INST OF HLTH NIAID
Aug 2020
– Mar 2022
TB Physicians Consultation Network
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Dec 2019
– Dec 2022
Performance Evaluation of the VIDAS TB IGRA Assay
Role: Principal Investigator
Funding: BIOMERIEUX
Jan 2018
– Dec 2022
SNTC 2018 TB COE Cooperative Agreement Submission.
Role: Principal Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Nov 2017
– Jul 2019
Florida Integrated Food Safety Center of Excellence
Role: Principal Investigator
Funding: FL DEPT OF HLTH
via CTRS FOR DISEASE CONTROL AND PREVENTION
Nov 2016
– Apr 2017
Florida Integrated Food Safety Center of Excellence
Role: Principal Investigator
Funding: FL DEPT OF HLTH
via CTRS FOR DISEASE CONTROL AND PREVENTION
Apr 2016
– Jun 2016
Florida Integrated Food Safety Center of Excellence
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Mar 2016
– Jul 2018
BacT/ALERT MP Improvement
Role: Principal Investigator
Funding: BIOMERIEUX
Nov 2015
– Apr 2016
Florida Integrated Food Safety Center of Excellence
Role: Project Manager
Funding: FL DEPT OF HLTH
via CTRS FOR DISEASE CONTROL AND PREVENTION
Jul 2014
– Jun 2020
TB Physicians Consultation Network
Role: Principal Investigator
Funding: FL DEPT OF HLTH
via CTRS FOR DISEASE CONTROL AND PREVENTION
Jan 2013
– Dec 2017
Tuberculosis Regional Training and Medical Consultation Centers
Role: Principal Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Sep 2011
– Sep 2021
TBESC: Prospective Comparison of the Tuberculin Skin Test (TST) vs. Interferon Gamma Release Assays (IGRAs) in Diagnosing Latent Tuberculosis Infection (LTBI)
Role: Co-Investigator
Funding: CTRS FOR DISEASE CONTROL AND PREVENTION
Mar 2008
ACTIVE
Virginia TB Foundation
Role: Principal Investigator
Funding: TUBERCULOSIS FOUNDATION OF VIRGINIA
Education
Residency – Pulmonary Disease and Critical Care
1997
·
University of Florida
Residency – Internal Medicine
1994
·
Carolinas Medical Center
Medical Degree
1991
·
University of Florida
Contact Details
Phones:
- Business:
- (352) 273-9378
Emails:
- Business:
- mike.lauzardo@medicine.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 103600
GAINESVILLE FL 32610 - Business Street:
-
2055 MOWRY RD STE 250
GAINESVILLE FL 32610